142 related articles for article (PubMed ID: 17976350)
1. Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?
Tefferi A
Mayo Clin Proc; 2007 Nov; 82(11):1316-8. PubMed ID: 17976350
[No Abstract] [Full Text] [Related]
2. Erythropoietin use in CKD patients with cancer: to tread with caution?
Nayak-Rao S; McCormick B
J Nephrol; 2013; 26(5):829-35. PubMed ID: 24052463
[TBL] [Abstract][Full Text] [Related]
3. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
Nowrousian MR; Dunst J; Vaupel P
Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
[TBL] [Abstract][Full Text] [Related]
4. Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
Bennett CL; Lai SY; Sartor O; Georgantopoulos P; Hrushesky WJ; Henke M; Armitage JO
JAMA Oncol; 2016 Jan; 2(1):134-6. PubMed ID: 26606114
[No Abstract] [Full Text] [Related]
5. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
6. Erythropoietin and radiotherapy: a dangerous combination?
Dunst J
Strahlenther Onkol; 2004 Mar; 180(3):133-5. PubMed ID: 15032246
[No Abstract] [Full Text] [Related]
7. Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms.
Hadland BK; Longmore GD
J Clin Oncol; 2009 Sep; 27(25):4217-26. PubMed ID: 19636005
[TBL] [Abstract][Full Text] [Related]
8. Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia".
Coiffier B
Oncologist; 2005 Oct; 10(9):762-3; author reply 764-5. PubMed ID: 16249359
[No Abstract] [Full Text] [Related]
9. 2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.
Marec-Berard P; Chastagner P; Kassab-Chahmi D; Casadevall N; Marchal C; Misset JL; Ray-Coquard I
Pediatr Blood Cancer; 2009 Jul; 53(1):7-12. PubMed ID: 19229970
[TBL] [Abstract][Full Text] [Related]
10. [Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX; Meng FJ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
[No Abstract] [Full Text] [Related]
11. Darbepoetin alfa and chronic kidney disease.
Locatelli F; Del Vecchio L; Casartelli D
N Engl J Med; 2010 Feb; 362(7):654-5; author reply 655. PubMed ID: 20187259
[No Abstract] [Full Text] [Related]
12. Cancer- and treatment-related anemia.
Rodgers GM; Cella D; Chanan-Khan A; Chesney C; Cleeland C; Coccia PF; Demetri GD; Djulbegovic B; Garst JL; Gore M; Kraut EH; Lin WC; Millenson M; Mock V; Reinke D; Rosenthal J; Sabbatini P
J Natl Compr Canc Netw; 2005 Nov; 3(6):772-89. PubMed ID: 16316613
[No Abstract] [Full Text] [Related]
13. An ongoing study of anemia correction in chronic kidney disease.
Pfeffer MA;
N Engl J Med; 2007 Mar; 356(9):959-61. PubMed ID: 17329707
[No Abstract] [Full Text] [Related]
14. Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia.
Lappin TR; Maxwell AP; Johnston PG
Oncologist; 2007 Apr; 12(4):362-5. PubMed ID: 17470677
[No Abstract] [Full Text] [Related]
15. Post transplantation anemia: re-emphasizing the use of erythropoietin.
Jabur WL
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):104-6. PubMed ID: 21196622
[No Abstract] [Full Text] [Related]
16. Erythropoietin may impair, not improve, cancer survival.
Brower V
Nat Med; 2003 Dec; 9(12):1439. PubMed ID: 14647499
[No Abstract] [Full Text] [Related]
17. [Concern about the safety of erythropoietin in cancer patients].
van der Lelie J
Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin-stimulating agents: new data yield new insights.
Zitella L
Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):36-8. PubMed ID: 18154208
[No Abstract] [Full Text] [Related]
19. Is anemia of cancer different from chemotherapy-induced anemia?
Steensma DP
J Clin Oncol; 2008 Mar; 26(7):1022-4. PubMed ID: 18227523
[No Abstract] [Full Text] [Related]
20. Weighing the hazards of erythropoiesis stimulation in patients with cancer.
Khuri FR
N Engl J Med; 2007 Jun; 356(24):2445-8. PubMed ID: 17568023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
